NEW YORK (GenomeWeb) — Following its agreement with Pacific Biosciences last year to develop a sequencing platform for clinical diagnostics, Roche put its strategy for next-generation sequencing on a second leg this week by agreeing to acquire single-molecule nanopore sequencing startup Genia for up to $350 million.

Under the terms of the deal, expected to close soon, Roche will pay $125 million in cash and up to another $225 million tied to milestones.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.